MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

MDT

85.6

-1.76%↓

118.07

-1.12%↓

VEEV

167.35

-0.11%↓

HQY

84.4

+0.63%↑

NEOG

9.24

-2.01%↓

Home・Aandelen Lijst・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Gesloten

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

Odonate Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 apr 2026, 23:14 UTC

Winsten

Battery Maker CATL First-Quarter Net Rose on Strong Demand

15 apr 2026, 23:14 UTC

Winsten

Battery Maker CATL First Quarter Net Rose On Strong Demand

15 apr 2026, 17:13 UTC

Belangrijke Marktbewegers

Tesla Shares Rise on Completion of AI5 Chip Design Process

15 apr 2026, 23:39 UTC

Marktinformatie

Nikkei May Rise After Gains on Wall Street -- Market Talk

15 apr 2026, 23:35 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

15 apr 2026, 22:41 UTC

Winsten

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

15 apr 2026, 22:38 UTC

Winsten

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

15 apr 2026, 22:15 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 apr 2026, 22:15 UTC

Marktinformatie

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

15 apr 2026, 22:14 UTC

Winsten

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

15 apr 2026, 22:12 UTC

Winsten

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

15 apr 2026, 22:11 UTC

Winsten

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

15 apr 2026, 22:11 UTC

Winsten

Lens Technology Swings to Loss in 1Q>300433.SZ

15 apr 2026, 22:07 UTC

Winsten

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

15 apr 2026, 21:34 UTC

Acquisities, Fusies, Overnames

Skild AI Acquires Zebra Technologies' Robotics Automation Business

15 apr 2026, 21:29 UTC

Populaire aandelen

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

15 apr 2026, 20:50 UTC

Marktinformatie

Winsten

Financial Services Roundup: Market Talk

15 apr 2026, 20:30 UTC

Winsten

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

15 apr 2026, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

15 apr 2026, 20:06 UTC

Marktinformatie

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

15 apr 2026, 19:46 UTC

Winsten

Acquisities, Fusies, Overnames

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

15 apr 2026, 19:25 UTC

Marktinformatie

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

15 apr 2026, 19:00 UTC

Marktinformatie

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

15 apr 2026, 18:58 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

15 apr 2026, 18:11 UTC

Acquisities, Fusies, Overnames

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

15 apr 2026, 17:45 UTC

Acquisities, Fusies, Overnames

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

15 apr 2026, 16:58 UTC

Winsten

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

15 apr 2026, 16:52 UTC

Winsten

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

15 apr 2026, 16:46 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

15 apr 2026, 16:37 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Odonate Therapeutics Inc Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

EBITDA

Operationele winst

Over Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.